4.5 Article Retracted Publication

被撤回的出版物: Sirtuin-3 modulates Bak- and Bax-dependent apoptosis (Publication with Expression of Concern. See vol. 129, pg. 871, 2016) (Publication with Expression of Concern. See vol. 129, pg. 871, 2016) (Retracted article. See vol. 129, pg. 2687, 2016)

Journal

JOURNAL OF CELL SCIENCE
Volume 126, Issue 1, Pages 274-288

Publisher

COMPANY BIOLOGISTS LTD
DOI: 10.1242/jcs.115188

Keywords

Sirtuin-3; Mitochondria; Hexokinase-2; Bak; Bax; Apoptosis; Cisplatin

Categories

Funding

  1. National Institutes of Health [5R01CA118356, 5R01AA01287]
  2. NATIONAL CANCER INSTITUTE [R01CA118356] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Sirtuin-3 exhibits properties of a tumor suppressor partly emanating from its ability to control the state of mitochondrial metabolism, with depletion of sirt-3 increasing tumor cell survival. In the present study we demonstrate that depletion of sirtuin-3 brings about an anti-apoptotic phenotype via stimulating cyclophilin-D activity, which promotes the binding of hexokinase II to the mitochondria, thereby preventing Bak/Bax dependent mitochondrial injury and cell death. By contrast, increased expression of sirtuin-3 decreases cyclophilin-D activity, resulting in detachment of hexokinase II from the mitochondria and potentiation of Bak- and Bax-induced mitochondrial injury and loss of cell viability.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available